Clinical trials provide patients with relapsed or treatment-resistant lymphoma access to emerging therapies, making conversations with providers essential, according to Dr. Jennif ...

Dr. Wendy Woodward discussed the transformative rise of hypofractionated radiation. For years, the "daily grind" of breast cancer treatment meant six weeks of grueling hospital visits — a significant ...

Paul McKenzie, a liver cancer survivor, and his wife, Emma, sat down with CURE to discuss the critical role of self advocacy, ...

The FDA approved a steroid-sparing Tecvayli and Darzalex Faspro combo for relapsed myeloma, offering an 83% reduction in ...

Sunvozertinib achieved a statistically significant, clinically meaningful PFS advantage over platinum-based chemotherapy by ...

Louis shares her journey of navigating a metastatic breast cancer diagnosis and chemotherapy while pregnant with the help of ...

shares her journey of navigating a metastatic breast cancer diagnosis and chemotherapy while pregnant with the help of her oncology team.

A living liver donor shares recovery, fatigue and the lasting reward of helping his father heal after transplant surgery.

Dr. Hope Rugo and advocate Jonise Louis discuss new ADCs, biomarker testing, and patient-centered dosing for metastatic ...

A couple shares how open communication reshaped their relationship during and after liver cancer treatment. Paul McKenzie, a ...

As of 2025, there are over 18.6 million cancer survivors in the United States, representing about 1 in 18 Americans. By the ...

Paul, a liver cancer survivor, and his wife Emma share their journey of recovery, caregiving and finding balance in life ...